AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Nykode Therapeutics ASA

Major Shareholding Notification Oct 14, 2025

3695_mrq_2025-10-14_1a1aabb6-efed-4d90-b878-996f16ddb062.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

SMALLCAP World Fund, Inc. 333 South Hope Street Los Angeles, CA 90071-1406

capitalgroup.com

13 October 2025

Nykode Therapeutics ASA

[email protected]

Oslo Bors AS (Oslo Stock Exchange) 011 47 22 41 67 90 [email protected]

Norwegian Central Depository (VPS) 011 47 22 63 52 00 [email protected]

Re: SMALLCAP World Fund, Inc. - Disclosure of acquisition/disposition of large shareholdings - Nykode Therapeutics ASA (the "Company")

Pursuant to Section 4-3 of the Norwegian Securities Trading Act and the Securities Trading Act Regulations, we hereby disclose the following information.

On 10 October 2025, SCWF acquired 75,057 shares of the Company, resulting in a shareholding amounting to 5.018% of total voting rights and 5.018% of total share capital. Please see the enclosed Schedule A for transaction details and Schedule B for the number of shares in the Company held by SCWF in respect of which this notification relates.

Please note that the notification submitted on behalf of The Capital Group Companies, Inc. as of 10 October 2025 included SCWF's holdings.

For the purpose of this Report, the total voting rights figure of 326,546,444 votes and the total share capital figure of 326,546,444 shares were used to calculate the percentages. We believe these figures are correct; however, if these numbers are not accurate, please contact us as soon as possible so we may make the necessary revisions.

Should you have questions or require additional information, please contact us at (213) 486-9200 or via e-mail at [email protected].

Regards,

_____________________ Aisha Aden

Schedule A - Nykode Therapeutics ASA Transactions by SMALLCAP World Fund, Inc. As of 10 October 2025

Date of
transaction
Nature of change Price per share Class and number of
securities transacted
Votes affected
10 Oct 2025 Purchase 2.1102 NOK 75,057 Common Stock 75,057

Schedule B - Nykode Therapeutics ASA Holdings by SMALLCAP World Fund, Inc. As of 10 October 2025

Total Shares = Actual Shares + Lent Shares

Fune Number of Percent of total Number of Percent of total
Votes voting rights Shares shares
SMALLCAP World Fund, Inc. 16,387,015 5.018% 16,387,015 5.018%

Actual Shares

Fune Number of Percent of total Number of Percent of total
Votes voting rights Shares shares
SMALLCAP World Fund, Inc. 16,387,015 5.018% 16,387,015 5.018%

Lent Shares

Fune Number of Percent of total Number of Percent of total
Votes voting rights Shares shares
SMALLCAP World Fund, Inc. 0 0.000% 0 0.000%

Talk to a Data Expert

Have a question? We'll get back to you promptly.